|Day's Range||75.93 - 76.65|
|52 Week Range||69.30 - 98.67|
|PE Ratio (TTM)||15.98|
|Dividend & Yield||2.00 (2.61%)|
|1y Target Est||N/A|
Which pharmacy stock wins in a head-to-head battle between rivals CVS Health and Walgreens Boots Alliance?
More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.
CVS Health Corp's Omnicare unit has agreed to pay $23 million to resolve a whistleblower lawsuit alleging that it took kickbacks from a drugmaker to promote two antidepressants, according to settlement papers released on Friday. The accord, confirmed by the U.S. Attorney's Office in Boston, will resolve a lawsuit against the pharmacy operator filed in 2007 by two former employees of drugmaker Organon USA Inc on behalf of the federal government and various states. CVS in a statement said the alleged conduct at issue took place before it acquired Omnicare in 2015.